Liposomal Formulations of Anti-Alzheimer Drugs and siRNA for Nose-to-Brain Delivery: Design, Safety and Efficacy In Vitro
Crossref DOI link: https://doi.org/10.1208/s12248-024-00967-x
Published Online: 2024-09-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lee, David
Shen, Andrew M
Garbuzenko, Olga B
Minko, Tamara https://orcid.org/0000-0002-1633-4705
Text and Data Mining valid from 2024-09-04
Version of Record valid from 2024-09-04
Article History
Received: 11 July 2024
Accepted: 15 August 2024
First Online: 4 September 2024
Declarations
:
: The authors declare no conflicts of interest.